Operating Lease, Right-of-Use Asset of ADMA BIOLOGICS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ADMA BIOLOGICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • ADMA BIOLOGICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $6,650,000, a 23% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,650,000 -$1,984,000 -23% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $9,271,000 +$374,000 +4.2% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $8,961,000 -$191,000 -2.1% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $8,020,000 -$1,377,000 -15% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $8,634,000 -$1,001,000 -10% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $8,897,000 -$856,725 -8.8% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $9,152,000 -$851,826 -8.5% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,397,000 -$850,700 -8.3% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $9,635,000 -$850,000 -8.1% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $9,753,725 -$582,148 -5.6% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $10,003,826 -$546,410 -5.2% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $10,247,700 +$3,141,058 +44% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $10,485,000 +$3,222,342 +44% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $10,335,873 +$3,644,930 +54% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $10,550,236 +$3,721,196 +54% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $7,106,642 +$909,347 +15% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $7,262,658 +$3,003,467 +71% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $6,690,943 +$3,907,956 +140% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $6,829,040 +$5,129,040 +302% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $6,197,295 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $4,259,191 +$3,014,162 +242% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $2,782,987 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,700,000 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q4 2019 $1,245,029 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.